BioSpace News Archive

Press Releases

Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease

June 10, 2026
·
6 min read
Press Releases

N-Zyme Biomedical Begins Phase 2 Trial of First Pepsin Inhibitor for Reflux Disease

June 10, 2026
·
2 min read
Press Releases

Orionis Biosciences Announces Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines

June 10, 2026
·
2 min read
Press Releases

Auragens Achieves AABB Accreditation, Marking Major Milestone in Regenerative Medicine Quality and Patient Safety

June 10, 2026
·
4 min read
Press Releases

Polyrizon Receives Notice of European Patent Publication for Innovative Mucoadhesive Nasal Drug Delivery Technology

June 10, 2026
·
5 min read
Press Releases

Parexel to Showcase Seven Research Posters and Debut New Hematology Playbook at the European Hematology Association Congress 2026

June 10, 2026
·
6 min read
Press Releases

Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success

June 10, 2026
·
6 min read
Press Releases

Tris Pharma Announces FDA Grant of Orphan Drug Designation for TRN-257 (Oxybate for Extended-Release Oral Suspension) a Once-Nightly, Low-Sodium Oxybate Product for Idiopathic Hypersomnia

June 10, 2026
·
4 min read
Press Releases

CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies

June 10, 2026
·
14 min read
Press Releases

Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases

June 10, 2026
·
17 min read